Technologies related to Vaccine

Title
Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development
Ref: E-009-2018-0 | Updated: Feb 26, 2019
High-throughput assay for detection of rabies neutralizing antibodies
Ref: E-224-2018-0 | Updated: Oct 17, 2018
Human Retrovirus Obtained from Infected Chimpanzee Exposure
Ref: E-251-2013-0 | Updated: Sep 10, 2018
Antibodies for Rabies Post-exposure Prophylaxis or Antiviral Therapy of Clinical Rabies
Ref: E-263-2013-0 | Updated: Jul 16, 2018
New Anti-Influenza Virus Neuraminidase 9 (N9) Monoclonal Antibody – for Prevention or Treatment of H7N9 Influenza (Flu) A with Less Likelihood of Drug Resistance
Ref: E-200-2016-0 | Updated: Jun 20, 2018
Method to Remove Mycoplasma Contamination from Virus Stocks
Ref: E-039-2018-0 | Updated: Jun 13, 2018
Novel Peptide of Streptococcus pneumoniae Surface Adhesion A (PsaA) Protein Associated with Adherence and Uses Thereof – for Vaccine Candidate, Therapeutic and Diagnostic Development
Ref: E-338-2013-0 | Updated: Jun 13, 2018
WR (Western Reserve) Strain of Vaccinia Virus with K151E Mutation in A34R Gene
Ref: E-263-2015-0 | Updated: Jun 7, 2018
Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
Ref: E-159-2013-0 | Updated: Jun 7, 2018
Chlamydial Vaccine Technologies
Ref: E-031-2006-0 | Updated: Mar 28, 2018
Novel Human Rotavirus Vaccine CDC-6 Strain for Impacted Subgroup, the Lewis Negative Population
Ref: E-285-2015-0 | Updated: May 4, 2018
West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
Ref: E-177-2016/0 | Updated: Dec 21, 2017
West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
Ref: E-177-2016-0 | Updated: Dec 21, 2017
Chimeric Dengue/Zika Viruses for Live-Attenuated Zika Vaccine Development
Ref: E-178-2016-0 | Updated: Sep 17, 2018
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016-0 | Updated: Jun 22, 2018
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011-0 | Updated: May 16, 2018
Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
Ref: E-195-2014/0 | Updated: Dec 1, 2016
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
Recombinant Paramyxoviruses Expressing Optimized Heterologous Antigens
Ref: E-241-2014/0 | Updated: Jun 27, 2017
Live Attenuated Japanese Encephalitis Virus Vaccine
Ref: E-231-2014/0 | Updated: Jul 1, 2015
A Novel Virus-Based Expression System
Ref: E-181-2014/0 | Updated: Aug 18, 2015
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012/0 | Updated: Aug 11, 2015
Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
Ref: E-101-2010/0 | Updated: Sep 21, 2015
Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases
Ref: E-159-2009/0 | Updated: Oct 23, 2017
Recombinant Vaccines Based on Poxvirus Vectors
Ref: E-552-1982/2 | Updated: Aug 18, 2015
Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus
Ref: E-357-2001-1 | Updated: Sep 10, 2015
Subscribe to Technologies related to Vaccine